T3 Augmentation in Major Depressive Disorder: Safety Considerations

被引：14
|
作者：
Rosenthal, Lisa J. [1 ]
Goldner, Whitney S.
O'Reardon, John P.
机构：
[1] Northwestern Univ, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2011年 / 168卷 / 10期
关键词：
TRICYCLIC ANTIDEPRESSANT RESPONSE; LEVOTHYROXINE PLUS LIOTHYRONINE; ASTERISK-D REPORT; THYROID-HORMONE; DOUBLE-BLIND; PRIMARY HYPOTHYROIDISM; REPLACEMENT THERAPY; L-THYROXINE; TRIIODOTHYRONINE AUGMENTATION; REFRACTORY DEPRESSION;
D O I：
10.1176/appi.ajp.2011.10030402
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页码：1035 / 1040
页数：6
相关论文
共 50 条
  • [1] Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Safety and Tolerability
    Papakostas, George
    Fava, Maurizio
    Mischoulon, David
    Shelton, Richard
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S146 - S147
  • [2] The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder
    Garlow, Steven J.
    Dunlop, Boadie W.
    Ninan, Philip T.
    Nemeroff, Charles B.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2012, 46 (11) : 1406 - 1413
  • [3] EFFICACY, SAFETY, AND TOLERABILITY CONSIDERATIONS IN THE NOVEL TREATMENT OF MAJOR DEPRESSIVE DISORDER
    Nierenberg, Andrew
    Kennedy, Sidney
    Lydiard, R. Bruce
    Rapaport, Mark Hyman
    [J]. CNS SPECTRUMS, 2009, 14 (03) : 1 - +
  • [4] Long term augmentation with T3 in refractory major depression
    Kelly, Tammas F.
    Lieberman, Daniel Z.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 115 (1-2) : 230 - 233
  • [5] Augmentation of Dopaminergic Agents for Major Depressive Disorder
    Pae, Chi-Un
    Patkar, Ashwin A.
    Masand, Prakash S.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (03) : 432 - 433
  • [6] Is augmentation with folate effective for major depressive disorder?
    Trincado, Javier
    Caneo, Constanza
    [J]. MEDWAVE, 2018, 18 (01):
  • [7] Augmentation strategies in the treatment of major depressive disorder
    Bise, S.
    Kurtovic, B.
    Begic, D.
    Cemalovic, O.
    [J]. EUROPEAN PSYCHIATRY, 2016, 33 : S407 - S407
  • [8] Biomarkers for Major Depressive Disorder: Economic Considerations
    Bogavac-Stanojevic, Natasa
    Lakic, Dragana
    [J]. DRUG DEVELOPMENT RESEARCH, 2016, 77 (07) : 374 - 378
  • [9] Modafinil as antidepressant augmentation therapy in major depressive disorder
    Thase, ME
    DeBattista, C
    Fava, M
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S210 - S211
  • [10] Use of Risperidone as Augmentation Treatment for Major Depressive Disorder
    Owenby, Ryan K.
    Brown, Lindsey T.
    Brown, Jamie N.
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (01) : 95 - 100
12345